Skip to Content

4890 SB (Requip 0.25 mg)

Generic Name: ropinirole

Pill imprint 4890 SB has been identified as Requip 0.25 mg.

Requip is used in the treatment of restless legs syndrome; parkinson's disease; periodic limb movement disorder and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Requip 0.25 mg is not a controlled substance under the Controlled Substance Act (CSA).

Requip 0.25 mg 4890 SB Front
Requip 0.25 mg 4890 SB Back
Requip 0.25 mg 4890 SB
Requip 0.25 mg 4890 SB
Requip
Generic Name:
ropinirole
Imprint:
4890 SB
Strength:
0.25 mg
Color:
White
Size:
8.00 mm
Shape:
Five-sided
Availability:
Prescription only
Drug Class:
Dopaminergic antiparkinsonism agents
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Manufacturer:
GlaxoSmithKline
National Drug Code (NDC):
00007-4890
Inactive Ingredients:
croscarmellose sodium
lactose monohydrate
magnesium stearate
microcrystalline cellulose
hypromellose 2910 (3 mPa.s)
polyethylene glycol 400
polysorbate 80
titanium dioxide
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
68387-0198 Keltman Pharmaceuticals Inc (repackager)
35356-0522 Lake Erie Medical and Surgical Supply (repackager)

Note: Inactive ingredients may vary.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide